{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:13:14Z","timestamp":1758960794628},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T00:00:00Z","timestamp":1384560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s40258-013-0069-2","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T09:07:48Z","timestamp":1384506468000},"page":"41-49","source":"Crossref","is-referenced-by-count":10,"title":["The Cost Effectiveness of Implantable Cardioverter Defibrillators: A Systematic Review of Economic Evaluations"],"prefix":"10.1007","volume":"12","author":[{"given":"Fotini","family":"Gialama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Prezerakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos","family":"Maniadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,16]]},"reference":[{"issue":"21","key":"69_CR1","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1161\/01.CIR.98.21.2334","volume":"98","author":"DP Zipes","year":"1998","unstructured":"Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98(21):2334\u201351.","journal-title":"Circulation"},{"key":"69_CR2","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1161\/01.CIR.0000129322.97266.F3","volume":"109","author":"M Josephson","year":"2004","unstructured":"Josephson M, Wellens HJ. Implantable defibrillators and sudden cardiac death. Circulation. 2004;109:2685\u201391.","journal-title":"Circulation"},{"key":"69_CR3","doi-asserted-by":"crossref","unstructured":"Myerburg RJ et al. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol. 1997;80(suppl. 5B):10F\u20139F.","DOI":"10.1016\/S0002-9149(97)00477-3"},{"issue":"1","key":"69_CR4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1377\/hlthaff.26.1.25","volume":"26","author":"ML Weisfeldt","year":"2007","unstructured":"Weisfeldt ML, Zieman SJ. Advances in the prevention and treatment of cardiovascular disease. Health Aff (Millwood). 2007;26(1):25\u201337.","journal-title":"Health Aff (Millwood)"},{"issue":"4","key":"69_CR5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2125.1998.t01-1-00768.x","volume":"46","author":"TJ Campbell","year":"1998","unstructured":"Campbell TJ, Williams KM. Therapeutic drug monitoring: antiarrhythmic drugs. Br J Clin Pharmacol. 1998;46(4):307\u201319.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"69_CR6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/hc0902.105131","volume":"105","author":"J Reiffel","year":"2002","unstructured":"Reiffel J, Dizon J. The implantable cardioverter-defibrillator: patient perspective. Circulation. 2002;105(9):1022\u20134.","journal-title":"Circulation"},{"key":"69_CR7","doi-asserted-by":"crossref","unstructured":"Epstein A, et al. ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol. 2008;51(21).","DOI":"10.1016\/j.jacc.2008.02.033"},{"key":"69_CR8","doi-asserted-by":"crossref","unstructured":"Liberati A, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7).","DOI":"10.1371\/journal.pmed.1000100"},{"issue":"1","key":"69_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18553\/jmcp.2003.9.1.53","volume":"9","author":"JJ Ofman","year":"2003","unstructured":"Ofman JJ, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manage Care Pharm. 2003;9(1):53\u201361.","journal-title":"J Manage Care Pharm"},{"issue":"3 Pt 1","key":"69_CR10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-8703(95)90359-3","volume":"130","author":"J Kupersmith","year":"1995","unstructured":"Kupersmith J, et al. Evaluating and improving the cost-effectiveness of the implantable cardioverter-defibrillator. Am Heart J. 1995;130(3 Pt 1):507\u201315.","journal-title":"Am Heart J"},{"issue":"1","key":"69_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/01.CIR.81.1.91","volume":"81","author":"M Kuppermann","year":"1990","unstructured":"Kuppermann M, et al. An analysis of the cost effectiveness of the implantable defibrillator. Circulation. 1990;81(1):91\u2013100.","journal-title":"Circulation"},{"issue":"17","key":"69_CR12","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/01.CIR.0000015504.57641.D0","volume":"105","author":"G Larsen","year":"2002","unstructured":"Larsen G, et al. Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy. Circulation. 2002;105(17):2049\u201357.","journal-title":"Circulation"},{"issue":"2","key":"69_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/hrt.68.8.241","volume":"68","author":"BJ O\u2019Brien","year":"1992","unstructured":"O\u2019Brien BJ, Buxton MJ, Rushby JA. Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysis. Br Heart J. 1992;68(2):241\u20135.","journal-title":"Br Heart J"},{"issue":"10","key":"69_CR14","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1161\/01.CIR.103.10.1416","volume":"103","author":"BJ O\u2019Brien","year":"2001","unstructured":"O\u2019Brien BJ, et al. Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS). Circulation. 2001;103(10):1416\u201321.","journal-title":"Circulation"},{"issue":"14","key":"69_CR15","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1161\/hc3901.096720","volume":"104","author":"R Sheldon","year":"2001","unstructured":"Sheldon R, et al. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study. Circulation. 2001;104(14):1622\u20136.","journal-title":"Circulation"},{"issue":"7","key":"69_CR16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0002-9343(02)01078-1","volume":"112","author":"JP Weiss","year":"2002","unstructured":"Weiss JP, et al. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries. Am J Med. 2002;112(7):519\u201327.","journal-title":"Am J Med"},{"issue":"3","key":"69_CR17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.CIR.93.3.489","volume":"93","author":"EF Wever","year":"1996","unstructured":"Wever EF, et al. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study. Circulation. 1996;93(3):489\u201396.","journal-title":"Circulation"},{"issue":"6","key":"69_CR18","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0735-1097(92)90341-J","volume":"19","author":"GC Larsen","year":"1992","unstructured":"Larsen GC, et al. Cost-effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol. 1992;19(6):1323\u201334.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"69_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-126-1-199701010-00001","volume":"126","author":"DK Owens","year":"1997","unstructured":"Owens DK, et al. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med. 1997;126(1):1\u201312.","journal-title":"Ann Intern Med"},{"issue":"3","key":"69_CR20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1067\/mhj.2002.125501","volume":"144","author":"DK Owens","year":"2002","unstructured":"Owens DK, et al. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. Am Heart J. 2002;144(3):440\u20138.","journal-title":"Am Heart J"},{"issue":"6","key":"69_CR21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/europace\/eup068","volume":"11","author":"MR Cowie","year":"2009","unstructured":"Cowie MR, et al. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. Europace. 2009;11(6):716\u201326.","journal-title":"Europace"},{"issue":"6","key":"69_CR22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jval.2011.02.1180","volume":"14","author":"A Gandjour","year":"2011","unstructured":"Gandjour A, et al. Cost-effectiveness of implantable defibrillators after myocardial infarction based on 8-year follow-up data (MADIT II). Value Health. 2011;14(6):812\u20137.","journal-title":"Value Health"},{"issue":"2","key":"69_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCULATIONAHA.105.581884","volume":"114","author":"DB Mark","year":"2006","unstructured":"Mark DB, et al. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 2006;114(2):135\u201342.","journal-title":"Circulation"},{"issue":"1","key":"69_CR24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00148365-200806010-00006","volume":"6","author":"M Neyt","year":"2008","unstructured":"Neyt M, et al. Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context. Appl Health Econ Health Policy. 2008;6(1):67\u201380.","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"69_CR25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1524-4733.2009.00608.x","volume":"13","author":"RA Ribeiro","year":"2010","unstructured":"Ribeiro RA, et al. Cost-effectiveness of implantable cardioverter-defibrillators in Brazil: primary prevention analysis in the public sector. Value Health. 2010;13(2):160\u20138.","journal-title":"Value Health"},{"issue":"5","key":"69_CR26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1590\/S0066-782X2010005000134","volume":"95","author":"RA Ribeiro","year":"2010","unstructured":"Ribeiro RA, et al. Cost-effectiveness of implantable cardioverter defibrillators in Brazil in the public and private sectors. Arq Bras Cardiol. 2010;95(5):577\u201386.","journal-title":"Arq Bras Cardiol"},{"issue":"10","key":"69_CR27","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-135-10-200111200-00007","volume":"135","author":"GD Sanders","year":"2001","unstructured":"Sanders GD, et al. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. Ann Intern Med. 2001;135(10):870\u201383.","journal-title":"Ann Intern Med"},{"issue":"14","key":"69_CR28","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMsa051989","volume":"353","author":"GD Sanders","year":"2005","unstructured":"Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005;353(14):1471\u201380.","journal-title":"N Engl J Med"},{"issue":"1","key":"69_CR29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ahj.2010.04.021","volume":"160","author":"GD Sanders","year":"2010","unstructured":"Sanders GD, et al. Cost-effectiveness of implantable cardioverter defibrillators in patients\u00a0>\u00a0or\u00a0=\u00a065\u00a0years of age. Am Heart J. 2010;160(1):122\u201331.","journal-title":"Am Heart J"},{"issue":"3","key":"69_CR30","first-page":"1","volume":"19","author":"GD Sanders","year":"2004","unstructured":"Sanders GD, et al. Special report: cost-effectiveness of implantable cardioverter-defibrillators in a MADIT-II population. Technol Eval Cent Assess Program Exec Summ. 2004;19(3):1\u20132.","journal-title":"Technol Eval Cent Assess Program Exec Summ"},{"issue":"1","key":"69_CR31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10916-007-9107-7","volume":"32","author":"K Wang","year":"2008","unstructured":"Wang K, et al. Cost-effectiveness of implantable cardioverter-defibrillators in Brugada syndrome treatment. J Med Syst. 2008;32(1):51\u20137.","journal-title":"J Med Syst"},{"issue":"5","key":"69_CR32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ahj.2007.06.026","volume":"154","author":"JJ You","year":"2007","unstructured":"You JJ, et al. Life expectancy gains and cost-effectiveness of implantable cardioverter\/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. Am Heart J. 2007;154(5):899\u2013907.","journal-title":"Am Heart J"},{"issue":"8","key":"69_CR33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/0003-4819-142-8-200504190-00007","volume":"142","author":"SM Al-Khatib","year":"2005","unstructured":"Al-Khatib SM, et al. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med. 2005;142(8):593\u2013600.","journal-title":"Ann Intern Med"},{"issue":"5","key":"69_CR34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.hrthm.2008.01.038","volume":"5","author":"PW Groeneveld","year":"2008","unstructured":"Groeneveld PW, et al. Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly. Heart Rhythm. 2008;5(5):646\u201353.","journal-title":"Heart Rhythm"},{"issue":"21","key":"69_CR35","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/01.CIR.97.21.2129","volume":"97","author":"AI Mushlin","year":"1998","unstructured":"Mushlin AI, et al. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. Circulation. 1998;97(21):2129\u201335.","journal-title":"Circulation"},{"issue":"11","key":"69_CR36","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jacc.2006.03.032","volume":"47","author":"J Zwanziger","year":"2006","unstructured":"Zwanziger J, et al. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006;47(11):2310\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"69_CR37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/B:CARD.0000029034.65769.f7","volume":"18","author":"L Chen","year":"2004","unstructured":"Chen L, Hay JW. Cost-effectiveness of primary implanted cardioverter defibrillator for sudden death prevention in congestive heart failure. Cardiovasc Drugs Ther. 2004;18(2):161\u201370.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"9","key":"69_CR38","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cardfail.2010.04.009","volume":"16","author":"B Feingold","year":"2010","unstructured":"Feingold B, et al. Cost-effectiveness of implantable cardioverter-defibrillators in children with dilated cardiomyopathy. J Card Fail. 2010;16(9):734\u201341.","journal-title":"J Card Fail"},{"key":"69_CR39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1542-474X.2005.00070.x","volume":"10","author":"I Goldenberg","year":"2005","unstructured":"Goldenberg I, et al. Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias. Ann Noninvasive Electrocardiol. 2005;10:67\u201383.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"3","key":"69_CR40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/eurheartj\/ehs090","volume":"34","author":"T Smith","year":"2013","unstructured":"Smith T, et al. The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis. Eur Heart J. 2013;34(3):211\u20139.","journal-title":"Eur Heart J"},{"issue":"1","key":"69_CR41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1524-4733.2006.00140.x","volume":"10","author":"JJ Caro","year":"2007","unstructured":"Caro JJ, et al. Cost\u2013benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone. Value Health. 2007;10(1):13\u201322.","journal-title":"Value Health"},{"issue":"3","key":"69_CR42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1185\/03007990802695037","volume":"25","author":"HB Deniz","year":"2009","unstructured":"Deniz HB, et al. Cost\u2013benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada. Curr Med Res Opin. 2009;25(3):617\u201326.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"69_CR43","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jacc.2005.05.061","volume":"46","author":"Z Goldberger","year":"2005","unstructured":"Goldberger Z, et al. Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation. J Am Coll Cardiol. 2005;46(5):850\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"69_CR44","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/oxfordjournals.eurheartj.a014722","volume":"17","author":"R Valenti","year":"1996","unstructured":"Valenti R, et al. Impact of the implantable cardioverter-defibrillator on rehospitalizations. Eur Heart J. 1996;17(10):1565\u201371.","journal-title":"Eur Heart J"},{"issue":"14","key":"69_CR45","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jacc.2008.05.058","volume":"52","author":"R Tung","year":"2008","unstructured":"Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52(14):1111\u201321.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"69_CR46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1067\/mhj.2002.124049","volume":"144","author":"J Irvine","year":"2002","unstructured":"Irvine J, et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J. 2002;144(2):282\u20139.","journal-title":"Am Heart J"},{"issue":"9","key":"69_CR47","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1540-8159.1999.tb00623.x","volume":"22","author":"PB Namerow","year":"1999","unstructured":"Namerow PB, et al. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial. Pacing Clin Electrophysiol. 1999;22(9):1305\u201313.","journal-title":"Pacing Clin Electrophysiol"},{"key":"69_CR48","first-page":"166","volume":"9","author":"G Boriani","year":"2007","unstructured":"Boriani G, et al. Implantable cardioverter defibrillators: from evidence of trials to clinical practice. Eur Heart J Suppl. 2007;9:166\u201373.","journal-title":"Eur Heart J Suppl"},{"key":"69_CR49","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1161\/01.CIR.101.14.1638","volume":"101","author":"AJ Moss","year":"2000","unstructured":"Moss AJ. Implantable cardioverter defibrillator therapy: the sickest patients benefit the most. Circulation. 2000;101:1638\u201340.","journal-title":"Circulation"},{"issue":"25","key":"69_CR50","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.jacc.2007.02.058","volume":"49","author":"DS Lee","year":"2007","unstructured":"Lee DS, et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol. 2007;49(25):2408\u201315.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"69_CR51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCOUTCOMES.108.807123","volume":"2","author":"PS Chan","year":"2009","unstructured":"Chan PS, et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes. 2009;2(1):16\u201324.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"5","key":"69_CR52","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.amjcard.2011.04.022","volume":"108","author":"U Mezu","year":"2011","unstructured":"Mezu U, et al. Effectiveness of implantable defibrillators in octogenarians and nonagenarians for primary prevention of sudden cardiac death. Am J Cardiol. 2011;108(5):718\u201322.","journal-title":"Am J Cardiol"},{"issue":"12 Pt 2","key":"69_CR53","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.7326\/0003-4819-142-12_Part_2-200506211-00010","volume":"142","author":"L Hartling","year":"2005","unstructured":"Hartling L, et al. Challenges in systematic reviews of therapeutic devices and procedures. Ann Intern Med. 2005;142(12 Pt 2):1100\u201311.","journal-title":"Ann Intern Med"},{"issue":"12 Pt 2","key":"69_CR54","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.7326\/0003-4819-142-12_Part_2-200506211-00007","volume":"142","author":"M Pignone","year":"2005","unstructured":"Pignone M, et al. Challenges in systematic reviews of economic analyses. Ann Intern Med. 2005;142(12 Pt 2):1073\u20139.","journal-title":"Ann Intern Med"},{"issue":"9","key":"69_CR55","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/01.CIR.101.9.1067","volume":"101","author":"MS Stanton","year":"2000","unstructured":"Stanton MS, Bell GK. Economic outcomes of implantable cardioverter-defibrillators. Circulation. 2000;101(9):1067\u201374.","journal-title":"Circulation"},{"issue":"3","key":"69_CR56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hec.1486","volume":"19","author":"R Anderson","year":"2010","unstructured":"Anderson R. Systematic reviews of economic evaluations: utility or futility? Health Econ. 2010;19(3):350\u201364.","journal-title":"Health Econ"},{"issue":"5","key":"69_CR57","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/01.CIR.0000021408.40925.63","volume":"106","author":"DB Mark","year":"2002","unstructured":"Mark DB, Hlatky MA. Medical economics and the assessment of value in cardiovascular medicine: Part II. Circulation. 2002;106(5):626\u201330.","journal-title":"Circulation"},{"issue":"4","key":"69_CR58","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.CIR.0000021407.93752.7B","volume":"106","author":"DB Mark","year":"2002","unstructured":"Mark DB, Hlatky MA. Medical economics and the assessment of value in cardiovascular medicine: part I. Circulation. 2002;106(4):516\u201320.","journal-title":"Circulation"},{"key":"69_CR59","unstructured":"National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal; 2008."},{"issue":"1","key":"69_CR60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-7547-1-8","volume":"1","author":"R Hutubessy","year":"2003","unstructured":"Hutubessy R, Chisholm D, Edejer TT. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff Resour Alloc. 2003;1(1):8.","journal-title":"Cost Eff Resour Alloc"},{"key":"69_CR61","unstructured":"World Health Organization. Choosing interventions that are cost-effective (WHO-CHOICE); 2011. http:\/\/www.who.int\/choice\/costs\/CER_levels\/en\/index.html ."},{"issue":"2","key":"69_CR62","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.healthpol.2004.12.015","volume":"74","author":"E Adang","year":"2005","unstructured":"Adang E, et al. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions. Health Policy. 2005;74(2):146\u201356.","journal-title":"Health Policy"},{"issue":"10","key":"69_CR63","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1525-1497.1998.00211.x","volume":"13","author":"DK Owens","year":"1998","unstructured":"Owens DK. Interpretation of cost-effectiveness analyses. J Gen Intern Med. 1998;13(10):716\u20137.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"69_CR64","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1388-9842(03)00099-0","volume":"5","author":"G Boriani","year":"2003","unstructured":"Boriani G, et al. Cardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costs. Eur J Heart Fail. 2003;5(4):419\u201325.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"69_CR65","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/euhj.2000.2371","volume":"22","author":"G Boriani","year":"2001","unstructured":"Boriani G, et al. Cost-effectiveness of implantable cardioverter-defibrillators. Eur Heart J. 2001;22(12):990\u20136.","journal-title":"Eur Heart J"},{"issue":"9271","key":"69_CR66","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(00)05009-1","volume":"357","author":"MA Hlatky","year":"2001","unstructured":"Hlatky MA, Bigger T. Cost-effectiveness of the implantable cardioverter defibrillator? Lancet. 2001;357(9271):1817\u20138.","journal-title":"Lancet"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-013-0069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40258-013-0069-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-013-0069-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T11:39:55Z","timestamp":1647085195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40258-013-0069-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,16]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1007\/s40258-013-0069-2","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,16]]}}}